Haja, Baby Boy .
HRN: 22-01-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
09/30/2022
10/07/2022
IV
15mg
Q24
Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes